{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T12:00:38Z","timestamp":1784980838584,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100018928","name":"Instituto Tecnol\u00f3gico Metropolitano","doi-asserted-by":"publisher","award":["P23208"],"award-info":[{"award-number":["P23208"]}],"id":[{"id":"10.13039\/501100018928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12278-9","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T11:07:04Z","timestamp":1784977624000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cellular effects of combined Ctn-2 peptide and doxorubicin treatment in breast cancer cells: A preliminary study of membrane interaction, ROS production, and cell cycle distribution"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1110-6930","authenticated-orcid":false,"given":"Ana Mar\u00eda","family":"Sep\u00falveda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2391-7343","authenticated-orcid":false,"given":"Marcela","family":"Manrique-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda","family":"Echeverri-Gaviria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0514-5957","authenticated-orcid":false,"given":"Gloria A.","family":"Santa-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"12278_CR1","unstructured":"Ferlay J et al (2024) Global cancer observatory: cancer today. lyon, france: international agency for research on cancer. (consultado oct. 17, 2024) https:\/\/gco.iarc.who.int\/today"},{"key":"12278_CR2","doi-asserted-by":"publisher","unstructured":"Yin L, Duan J-J, Bian X-W, Yu yS-C (2020) Triple-negative breast cancer molecular subtyping and treatment progress, Breast Cancer Res 22(1):61. https:\/\/doi.org\/10.1186\/s13058-020-01296-5","DOI":"10.1186\/s13058-020-01296-5"},{"key":"12278_CR3","doi-asserted-by":"publisher","unstructured":"Collignon J, Lousberg L, Schroeder H, Jerusalem yG (2016) Triple-negative breast cancer: treatment challenges and solutions, Breast cancer Dove Med Press 8:93\u2013107. https:\/\/doi.org\/10.2147\/BCTT.S69488","DOI":"10.2147\/BCTT.S69488"},{"key":"12278_CR4","doi-asserted-by":"publisher","unstructured":"Medina MA et al (2078) Triple-negative breast cancer: a review of conventional and advanced therapeutic strategies, Int J Environ Res Public Health 17(6):2020. https:\/\/doi.org\/10.3390\/ijerph17062078","DOI":"10.3390\/ijerph17062078"},{"key":"12278_CR5","doi-asserted-by":"publisher","unstructured":"Kciuk M et al (2023) Doxorubicin\u2014An Agent with Multiple Mechanisms of Anticancer Activity. Cells 12(4):659. https:\/\/doi.org\/10.3390\/cells12040659","DOI":"10.3390\/cells12040659"},{"issue":"n\u2013m 5","key":"12278_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/emm.2006.63","volume":"38","author":"S-Y Kim","year":"2006","unstructured":"Kim S-Y et al (2006) Doxorubicin-induced reactive oxygen species generation and intracellular Ca2\u2009+\u2009increase are reciprocally modulated in rat cardiomyocytes. Exp Mol Med 38(n\u2013m 5):535\u2013545. https:\/\/doi.org\/10.1038\/emm.2006.63","journal-title":"Exp Mol Med"},{"key":"12278_CR7","doi-asserted-by":"publisher","unstructured":"B\u0142aszczak E, Miziak P, Odrzywolski A, Baran M, Gumbarewicz E, Stepulak yA (2025) Triple-negative breast cancer progression and drug resistance in the context of epithelial\u2013mesenchymal transition. Cancers (Basel) 17(2):228. https:\/\/doi.org\/10.3390\/cancers17020228","DOI":"10.3390\/cancers17020228"},{"key":"12278_CR8","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1186\/s12885-019-5939-z","volume":"19","author":"C Christowitz","year":"2019","unstructured":"Christowitz C, Davis T, Isaacs A, van Niekerk G, Hattingh S, Engelbrecht yA-M (2019) Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model. BMC Cancer 19:757. https:\/\/doi.org\/10.1186\/s12885-019-5939-z","journal-title":"BMC Cancer"},{"key":"12278_CR9","doi-asserted-by":"publisher","unstructured":"Vitale R, Marzocco S, Popolo yA (2024) Role of oxidative stress and inflammation in doxorubicin-induced cardiotoxicity: a brief account. Int J Mol Sci 25(13):7477. https:\/\/doi.org\/10.3390\/ijms25137477","DOI":"10.3390\/ijms25137477"},{"key":"12278_CR10","doi-asserted-by":"publisher","unstructured":"Wu K-Y et al (2025) Synergistic anticancer activity of HSP70 inhibitor and doxorubicin in gain-of-function mutated p53 breast cancer cells. Biomedicines 13(5);1034. https:\/\/doi.org\/10.3390\/biomedicines13051034","DOI":"10.3390\/biomedicines13051034"},{"key":"12278_CR11","doi-asserted-by":"publisher","unstructured":"Prada LC et al (2023) Doxorubicin activity is modulated by traditional herbal extracts in a 2D and 3D multicellular sphere model of leukemia. Pharmaceutics 15(6):1690. https:\/\/doi.org\/10.3390\/pharmaceutics15061690","DOI":"10.3390\/pharmaceutics15061690"},{"key":"12278_CR12","doi-asserted-by":"publisher","unstructured":"Raileanu M, Popescu A, Bacalum yM (2020) Antimicrobial peptides as new combination agents in cancer therapeutics: a promising protocol against HT-29 tumoral spheroids. Int J Mol Sci 21(18):6964. https:\/\/doi.org\/10.3390\/ijms21186964","DOI":"10.3390\/ijms21186964"},{"key":"12278_CR13","doi-asserted-by":"publisher","unstructured":"Deslouches y B, Di YP (2017) Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications. Oncotarget 8(28):46635\u201346651. https:\/\/doi.org\/10.18632\/oncotarget.16743","DOI":"10.18632\/oncotarget.16743"},{"key":"12278_CR14","doi-asserted-by":"publisher","first-page":"1310443","DOI":"10.3389\/fimmu.2024.1310443","volume":"15","author":"N Ghadiri","year":"2024","unstructured":"Ghadiri N et al (2024) Bioactive peptides: an alternative therapeutic approach for cancer management. Front Immunol 15:1310443. https:\/\/doi.org\/10.3389\/fimmu.2024.1310443","journal-title":"Front Immunol"},{"key":"12278_CR15","doi-asserted-by":"publisher","unstructured":"Zhang Y, Wang C, Zhang W, Li yX (2023) Bioactive peptides for anticancer therapies. Biomater Transl 4(1):5\u201317. https:\/\/doi.org\/10.12336\/biomatertransl.2023.01.003","DOI":"10.12336\/biomatertransl.2023.01.003"},{"key":"12278_CR16","doi-asserted-by":"publisher","unstructured":"Sep\u00falveda AM, Manrique-Moreno M, Echeverri-Gaviria S, Santa-Gonz\u00e1lez yGA (2026) Mechanistic insights into the anticancer activity of the crotalicidin-derived Ctn-2 peptide in triple-negative breast cancer. Sci Pharm 94(1):17. https:\/\/doi.org\/10.3390\/scipharm94010017","DOI":"10.3390\/scipharm94010017"},{"key":"12278_CR17","doi-asserted-by":"publisher","unstructured":"Foglietta F, Serpe L, Canaparo yR (2023) ROS-generating nanoplatforms as selective and tunable therapeutic weapons against cancer. Discov nano 18(1):151. https:\/\/doi.org\/10.1186\/s11671-023-03939-w","DOI":"10.1186\/s11671-023-03939-w"},{"key":"12278_CR18","doi-asserted-by":"publisher","unstructured":"Martell-Huguet EM et al (2025) The invertebrate-derived antimicrobial peptide cm-p5 induces cell death and ROS production in melanoma. Cells Mar Drugs 23(7):273. https:\/\/doi.org\/10.3390\/md23070273","DOI":"10.3390\/md23070273"},{"key":"12278_CR19","doi-asserted-by":"publisher","unstructured":"Ahmad I et al (2023) Antimicrobial peptide moricin induces ROS mediated caspase-dependent apoptosis in human triple-negative breast cancer via suppression of notch pathway, Cancer Cell Int 23(1):121. https:\/\/doi.org\/10.1186\/s12935-023-02958-y","DOI":"10.1186\/s12935-023-02958-y"},{"key":"12278_CR20","doi-asserted-by":"publisher","unstructured":"Tamtaji OR et al (2025) The effects of peptide IF7-conjugated dendrimer loaded with doxorubicin on colorectal cancer, Cancer Nanotechnol 16(11) https:\/\/doi.org\/10.1186\/s12645-025-00316-3","DOI":"10.1186\/s12645-025-00316-3"},{"key":"12278_CR21","doi-asserted-by":"publisher","unstructured":"R\u0103ileanu M, Bacalum yM (2023) Cancer wars: revenge of the amps (antimicrobial peptides), a new strategy against colorectal cancer, Toxins (Basel) 15(7):459. https:\/\/doi.org\/10.3390\/toxins15070459","DOI":"10.3390\/toxins15070459"},{"key":"12278_CR22","doi-asserted-by":"publisher","unstructured":"Bashi M, Madanchi H, Yousefi yB (2024) Investigation of cytotoxic effect and action mechanism of a synthetic peptide derivative of rabbit cathelicidin against MDA-MB-231 breast cancer cell line, Sci Rep 14(1)13497. https:\/\/doi.org\/10.1038\/s41598-024-64400-1","DOI":"10.1038\/s41598-024-64400-1"},{"key":"12278_CR23","doi-asserted-by":"publisher","unstructured":"Hsieh C-H, Wang T-Y, Tung B-C, Liu H-P, Yeh L-T, Hsu yK-C (2022) The hydrolytic peptides of soybean protein induce cell cycle arrest and apoptosis on human oral cancer cell line HSC-3, Molecules 27(9):2839. https:\/\/doi.org\/10.3390\/molecules27092839","DOI":"10.3390\/molecules27092839"},{"key":"12278_CR24","doi-asserted-by":"publisher","unstructured":"Saleh MA, Masoud HMM, Habib MR, AbdElGhany SR, Amer ME, y, Abouel-Nour MF (2025) Marine-derived peptides from Rapana venosa inhibit breast cancer cell growth through synergistic mechanisms with doxorubicin, Sci. Rep15(1):32451. https:\/\/doi.org\/10.1038\/s41598-025-18052-4","DOI":"10.1038\/s41598-025-18052-4"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12278-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12278-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12278-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T11:07:06Z","timestamp":1784977626000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12278-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12278"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12278-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies on human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1264"}}